CANOPY GROWTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.91 CAD | -3.57% |
|
-28.38% | +31.80% |
| Sales 2024 * | 320M 233M | Sales 2025 * | 302M 220M | Capitalization | 812M 590M |
|---|---|---|---|---|---|
| Net income 2024 * | -491M -357M | Net income 2025 * | -121M -87.99M | EV / Sales 2024 * | 3.87 x |
| Net Debt 2024 * | 427M 310M | Net Debt 2025 * | 403M 293M | EV / Sales 2025 * | 4.02 x |
| P/E ratio 2024 * |
-1.53
x | P/E ratio 2025 * |
-6.65
x | Employees | 1,621 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.96% |
More Fundamentals
* Assessed data
More news
Latest transcript on Canopy Growth Corporation
More recommendations
More press releases
More news
| 1 day | -3.57% | ||
| 1 week | -28.38% | ||
| Current month | -23.58% | ||
| 1 month | +113.16% | ||
| 3 months | +40.54% | ||
| 6 months | -6.21% | ||
| Current year | +31.80% |
1 week
8.39
11.74
1 month
4.5615.59
Current year
3.7415.59
1 year
3.7426.00
3 years
3.74358.00
5 years
3.74716.00
10 years
3.74766.80
| Managers | Title | Age | Since |
|---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 18-10-31 |
Judy Hong
DFI | Director of Finance/CFO | 52 | 19-12-01 |
Tyler Burns
IRC | Investor Relations Contact | - | 15-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Judy Schmeling
CHM | Chairman | 64 | 18-10-31 |
David Klein
CEO | Chief Executive Officer | 60 | 18-10-31 |
David Lazzarato
BRD | Director/Board Member | 69 | 20-03-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 8.91 | -3.57% | 2,333,685 |
| 24-04-16 | 9.24 | -3.65% | 1,909,348 |
| 24-04-15 | 9.59 | -10.37% | 2,552,341 |
| 24-04-12 | 10.7 | -3.95% | 2,439,495 |
| 24-04-11 | 11.14 | -10.45% | 3,679,518 |
Delayed Quote Toronto S.E., April 17, 2024 at 04:53 pm EDT
More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
Sector
Pharmaceuticals
Calendar
2024-05-29
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
8.91
CAD
Average target price
6.392
CAD
Spread / Average Target
-28.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +31.80% | 588M | |
| +37.12% | 6.02B | |
| -14.61% | 4.55B | |
| -10.58% | 3.13B | |
| +0.86% | 3.07B | |
| -0.94% | 2.57B | |
| +36.18% | 1.82B | |
| -10.82% | 1.63B | |
| -4.89% | 1.57B | |
| -12.50% | 1.54B |
- Stock Market
- Equities
- WEED Stock
